Immune response to E7 protein of human papillomavirus type 16 anchored on the cell surface
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
11904736
PubMed Central
PMC11034196
DOI
10.1007/s00262-001-0261-3
Knihovny.cz E-zdroje
- MeSH
- buněčná imunita MeSH
- experimentální nádory prevence a kontrola MeSH
- hemaglutininy virové imunologie MeSH
- interleukin-4 biosyntéza MeSH
- králíci MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- onkogenní proteiny virové analýza imunologie MeSH
- Papillomavirus E7 - proteiny MeSH
- protilátky virové biosyntéza MeSH
- rekombinantní fúzní proteiny imunologie MeSH
- vakcinace MeSH
- virové vakcíny imunologie MeSH
- virus vakcinie genetika MeSH
- zvířata MeSH
- Check Tag
- králíci MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- hemaglutininy virové MeSH
- interleukin-4 MeSH
- oncogene protein E7, Human papillomavirus type 16 MeSH Prohlížeč
- onkogenní proteiny virové MeSH
- Papillomavirus E7 - proteiny MeSH
- protilátky virové MeSH
- rekombinantní fúzní proteiny MeSH
- virové vakcíny MeSH
To target the E7 protein of human papilloma virus 16 to the cell surface, a fusion gene was constructed. It encodes the signal peptide, part of the immunoglobulin (IgG)-like domain, the transmembrane anchor of vaccinia virus (VV) hemagglutinin (HA), and the complete E7-coding sequence. The fusion gene was expressed under the HA late promoter by a recombinant VV, designated VV-E7-HA. The E7-HA protein was displayed on the surface of cells infected with the recombinant virus and was more stable than unmodified E7. The biological properties of the VV-E7-HA virus were compared with those of a VV-E7 virus that expressed the unmodified E7 and with a VV expressing the Sig-E7-LAMP fusion protein. While the first two of these recombinants were based on VV strain Praha, the third was derived from the WR strain of VV. Infection of mice with the VV-E7-HA virus induced the formation of E7-specific antibodies with the predominance of the IgG2a isotype, whereas the other two viruses did not induce the formation of E7-specific antibodies. Unlike the other two viruses, VV-E7-HA did not induce a response of cytotoxic T lymphocytes or Th1 cells and did not protect mice against the growth of E7-expressing tumors. Thus, VV-E7-HA induced a differently polarized immune response to the E7 protein than the other two viruses.
Citace poskytuje Crossref.org
Attenuation of vaccinia virus by the expression of human Flt3 ligand
Mutation in the immunodominant epitope of the HPV16 E7 oncoprotein as a mechanism of tumor escape
